Search Result "microenviroment design"
Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 1 Year: 2017 Page: 17-39
Author(s): Gang Wang,Xing-Li Fu,Jun-Jie Wang,Rui Guan,Xiang-Jun Tang
Biomaterials and Supercritical Fluid Technologies: Which Perspectives to Fabricate Artificial Extracellular Matrix?
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 26 Year: 2017 Page: 3759-3771
Author(s): G. Della Porta,E. Reverchon,N. Maffulli
Structure-controlled Nanomaterial Synthesis using Surfactant-assisted Ball Milling- A Review
Journal: Current Nanoscience
Volume: 10 Issue: 3 Year: 2014 Page: 344-354
Author(s): Mahbub Ullah, Md. Eaqub Ali, Sharifah Bee Abd Hamid
Carbon Nanotubes as A High-Performance Platform for Target Delivery of Anticancer Quinones
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 43 Year: 2018 Page: 5207-5218
Author(s): H.V. Grushevskaya,N.G. Krylova
Soft Matter Assemblies as Nanomedicine Platforms for Cancer Chemotherapy: A Journey from Market Products Towards Novel Approaches
Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 328-344
Author(s): Eliézer Jäger,Fernando C. Giacomelli
Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 4 Year: 2008 Page: 299-340
Author(s): Konstantin V. Balakin, Yan A. Ivanenkov, Sergey E. Tkachenko, Alex S. Kiselyov, Alexandre V. Ivachtchenko
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System?
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3560-3576
Author(s): Barbara Pavan, Alessandro Dalpiaz
Enzyme-responsive Nanoparticles for Anticancer Drug Delivery
Journal: Current Nanoscience
Volume: 12 Issue: 1 Year: 2016 Page: 38-46
Author(s): Tairong Kuang,Yarong Liu,Tiantian Gong,Xiangfang Peng,Xianglong Hu,Zhiqiang Yu
Predicting the Efficacy of Novel Synthetic Compounds in the Treatment ofOsteosarcoma via Anti-Receptor Activator of Nuclear Factor-κB Ligand(RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets
Journal: Medicinal Chemistry
Volume: 20 Issue: 7 Year: 2024 Page: 733-740
Author(s):
Disruptive Nanozyme Technology for Futuristic Bio-Medical and Bio-imaging Applications
Journal: Current Nanoscience
Volume: 17 Issue: 0 Year: 2021 Page: 1-18
Author(s): Lakshmipathy Muthukrishnan